Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficiency - Summary of Options Activity (Details)

v3.5.0.2
Stockholders' Deficiency - Summary of Options Activity (Details)
3 Months Ended
Mar. 31, 2016
USD ($)
$ / shares
shares
Equity [Abstract]  
Number of Shares Options Outstanding | shares 7,781,667
Number of Shares Options Granted | shares 65,000
Number of Shares Options Exercised | shares
Number of Shares Options Canceled/forfeited/expired | shares (146,667)
Number of Shares Options Outstanding | shares 7,700,000
Number of Shares Options Exercisable | shares 6,542,000
Weighted Average Exercise Price Options Outstanding | $ / shares $ 1.15
Weighted Average Exercise Price Options Granted | $ / shares 0.25
Weighted Average Exercise Price Options Exercised | $ / shares
Weighted Average Exercise Price Options Canceled/forfeited/expired | $ / shares 0.75
Weighted Average Exercise Price Options Outstanding | $ / shares 1.15
Weighted Average Exercise Price Option Exercisable | $ / shares $ 1.21
Weighted Average Remaining Life In Years Outstanding 2 years 3 months 18 days
Weighted Average Remaining Life In Years Exercisable 2 years 3 months 18 days
Aggregate Intrinsic Value Outstanding | $ $ 14,350
Aggregate Intrinsic Value Exercisable | $ $ 14,350